Propranolol Targets Hemangioma Stem Cells via cAMP and Mitogen-Activated Protein Kinase Regulation

A Randomized, Controlled Trial of Oral Propranolol in Infantile Hemangioma

(2015) Christine Léauté-Labrèze et al.   NEW ENGLAND JOURNAL OF MEDICINE

Propranolol Promotes Accelerated and Dysregulated Adipogenesis in Hemangioma Stem Cells

(2014) Ryan W. England et al.   ANNALS OF PLASTIC SURGERY

Propranolol targets the contractility of infantile haemangioma-derived pericytes

(2014) D. Lee et al.   BRITISH JOURNAL OF DERMATOLOGY

Propranolol vs Prednisolone for Symptomatic Proliferating Infantile Hemangiomas

(2014) Nancy M. Bauman et al.   JAMA Otolaryngology-Head & Neck Surgery

Infantile Hemangiomas

(2013) Eun-Kyung Mary Kwon et al.   AMERICAN JOURNAL OF CLINICAL DERMATOLOGY

The effectiveness of propranolol in treating infantile haemangiomas: a meta-analysis including 35 studies

(2013) Yin Lou et al.   BRITISH JOURNAL OF CLINICAL PHARMACOLOGY

Propranolol inhibits growth of hemangioma-initiating cells but does not induce apoptosis

(2013) Jina J.Y. Kum et al.   PEDIATRIC RESEARCH

Propranolol Accelerates Adipogenesis in Hemangioma Stem Cells and Causes Apoptosis of Hemangioma Endothelial Cells

(2013) Alvin Wong et al.   PLASTIC AND RECONSTRUCTIVE SURGERY

The role of β-adrenergic receptor signaling in the proliferation of hemangioma-derived endothelial cells

(2013) Yi Ji et al.   Cell Division

Propranolol Induces Regression of Hemangioma Cells Through HIF-1α–Mediated Inhibition of VEGF-A

(2012) Harvey Chim et al.   ANNALS OF SURGERY

Effects of propranolol on the proliferation and apoptosis of hemangioma-derived endothelial cells

(2012) Yi Ji et al.   JOURNAL OF PEDIATRIC SURGERY

Initiation and Use of Propranolol for Infantile Hemangioma: Report of a Consensus Conference

(2012) B. A. Drolet et al.   PEDIATRICS

A Randomized Controlled Trial of Propranolol for Infantile Hemangiomas

(2011) M. Hogeling et al.   PEDIATRICS

Distinct Phosphorylation Sites on the  2-Adrenergic Receptor Establish a Barcode That Encodes Differential Functions of  -Arrestin

(2011) K. N. Nobles et al.   Science Signaling

A switch in Notch gene expression parallels stem cell to endothelial transition in infantile hemangioma

(2010) June K. Wu et al.   ANGIOGENESIS

Propranolol for infantile haemangiomas: insights into the molecular mechanisms of action

(2010) C.H. Storch et al.   BRITISH JOURNAL OF DERMATOLOGY

Management of infantile subglottic hemangioma: Acebutolol or propranolol?

(2010) Catherine Blanchet et al.   INTERNATIONAL JOURNAL OF PEDIATRIC OTORHINOLARYNGOLOGY

Beta-adrenergic signals regulate adipogenesis of mouse mesenchymal stem cells via cAMP/PKA pathway

(2010) Haifang Li et al.   MOLECULAR AND CELLULAR ENDOCRINOLOGY

Propranolol suppresses angiogenesis in vitro: Inhibition of proliferation, migration, and differentiation of endothelial cells

(2010) Sylvie Lamy et al.   VASCULAR PHARMACOLOGY

Propranolol for Infantile Hemangiomas: Promise, Peril, Pathogenesis

(2009) Ilona J. Frieden et al.   PEDIATRIC DERMATOLOGY

Propranolol Treatment for Hemangioma of Infancy: Risks and Recommendations

(2009) Leslie P. Lawley et al.   PEDIATRIC DERMATOLOGY

Propranolol for Severe Infantile Hemangiomas: Follow-Up Report

(2009) V. Sans et al.   PEDIATRICS

Resection of Amblyogenic Periocular Hemangiomas: Indications and Outcomes

(2009) Jugpal S. Arneja et al.   PLASTIC AND RECONSTRUCTIVE SURGERY

Propranolol for Severe Hemangiomas of Infancy

(2008) Christine Léauté-Labrèze et al.   NEW ENGLAND JOURNAL OF MEDICINE

Dose translation from animal to human studies revisited

(2007) Shannon Reagan-Shaw et al.   FASEB JOURNAL